MARLBOROUGH, Mass.-- (BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) today announced the granting of a CE Mark to the LOCalizer™ wireless radio frequency identification (RFID) breast lesion localization ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) will reveal new technologies reimagining the future of breast health at the 110 th Scientific Assembly and Annual Meeting of the ...

Hologic, Inc. HOLX announced an extension of its LOCalizer radiofrequency identification (“RFID”) tag’s CE Mark. Under the extended approval, the tag can now be implanted more than 30 days prior to ...

Regulators in Europe gave the greenlight to Hologic Inc.’s Localizer, an implanted wireless device that promises to provide doctors greater flexibility to minimize the impact of breast surgery, the ...

Deal further expands Hologic’s portfolio of world-class breast health solutions addressing the full continuum of care The transaction supports Hologic’s strategy to provide a comprehensive suite of ...

Hologic Inc has acquired Somatex Medical Technologies, a provider of biopsy site markers and localization technologies, for approximately $64 million. The company was previously owned by E-Med ...